517 results on '"Yang, Hushan"'
Search Results
2. TFAM downregulation promotes autophagy and ESCC survival through mtDNA stress-mediated STING pathway
3. Redox sensitive miR-27a/b/Nrf2 signaling in Cr(VI)-induced carcinogenesis
4. Increased Drp1 promotes autophagy and ESCC progression by mtDNA stress mediated cGAS-STING pathway
5. Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors
6. Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway
7. Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer
8. Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients
9. An Effective Strategy to Eliminate Inherent Cross-Contamination in mtDNA Next-Generation Sequencing of Multiple Samples
10. Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update
11. Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA
12. Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
13. The Promise of Circulating Tumor Cells in Metastatic CRPC
14. 629-B Window of opportunity for durvalumab plus metformin trial in head & neck squamous cell carcinoma (HNSCC)
15. Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
16. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study
17. All Supplementary Figures and Tables from DNA Methylation of Telomere-Related Genes and Cancer Risk
18. Perspective on this Article from Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants
19. Supplementary Table 7 from Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants
20. Data from Global Assessment of Genetic Variation Influencing Response to Retinoid Chemoprevention in Head and Neck Cancer Patients
21. Data from DNA Methylation of Telomere-Related Genes and Cancer Risk
22. Supplementary Figure 1 from Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants
23. Supplementary Table 1 from Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants
24. Supplementary Table 4 from Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants
25. Supplementary Table 3 from Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants
26. Supplementary Table 5 from Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants
27. Perspective on This Article from Global Assessment of Genetic Variation Influencing Response to Retinoid Chemoprevention in Head and Neck Cancer Patients
28. Data from The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma
29. Data from Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants
30. Supplementary Tables 1-12 and Figures 1-3 from The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma
31. Supplementary Table 2 from Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants
32. Supplementary Table 6 from Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants
33. Supplementary Data from MicroRNA Expression Signatures in Barrett's Esophagus and Esophageal Adenocarcinoma
34. Supplementary Figure 1 from Genetic Polymorphisms in Pre-microRNA Genes as Prognostic Markers of Colorectal Cancer
35. Abstract P5-06-05: Whole-genome bisulfite sequencing of single circulating tumor cells identifies cellular methylation heterogeneity in metastatic breast cancer
36. Abstract P5-06-02: Circulating tumor cells in metastatic breast cancer highlight potential role of copy number evolution in late-stage cancer mutational profile
37. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways
38. AT-rich interactive domain 2, p110α, p53, and β-catenin protein expression in hepatocellular carcinoma and clinicopathologic implications
39. Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer
40. Factors Likely to Affect the Uptake of Genomic Approaches to Cancer Screening in Primary Care: A Scoping Review
41. Current Management of Locally Advanced Head and Neck Cancer: The Combination of Chemotherapy With Locoregional Treatments
42. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway
43. Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables
44. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer
45. TNFα induces Ca2+ influx to accelerate extrinsic apoptosis in hepatocellular carcinoma cells
46. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
47. Polymorphisms in genes related to epithelial–mesenchymal transition and risk of non-small cell lung cancer
48. Heparin Promotes Cardiac Differentiation of Human Pluripotent Stem Cells in Chemically Defined Albumin‐Free Medium, Enabling Consistent Manufacture of Cardiomyocytes
49. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer
50. The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.